Terumo Corporation (TRUMY)
USD 19.28
(-2.92%)
USD 19.28
(-2.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 339.07 Billion JPY | 13.01% |
| 2023 | 300.03 Billion JPY | 18.41% |
| 2022 | 253.38 Billion JPY | 11.02% |
| 2021 | 228.23 Billion JPY | -2.18% |
| 2020 | 233.32 Billion JPY | 6.12% |
| 2019 | 219.86 Billion JPY | 4.31% |
| 2018 | 210.77 Billion JPY | 4.65% |
| 2017 | 201.42 Billion JPY | -0.87% |
| 2016 | 203.19 Billion JPY | 7.76% |
| 2015 | 188.56 Billion JPY | 6.7% |
| 2014 | 176.72 Billion JPY | 15.9% |
| 2013 | 152.47 Billion JPY | 7.69% |
| 2012 | 141.59 Billion JPY | 30.87% |
| 2011 | 108.19 Billion JPY | 4.97% |
| 2010 | 103.06 Billion JPY | -1.09% |
| 2009 | 104.2 Billion JPY | 2.9% |
| 2008 | 101.26 Billion JPY | 6.73% |
| 2007 | 94.87 Billion JPY | 8.52% |
| 2006 | 87.42 Billion JPY | 14.04% |
| 2005 | 76.65 Billion JPY | 4.1% |
| 2004 | 73.64 Billion JPY | 9.34% |
| 2003 | 67.34 Billion JPY | -99.96% |
| 2002 | 186957.24 Billion JPY | 320977.91% |
| 2001 | 58.22 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 93.67 Billion JPY | 6.98% |
| 2024 Q1 | 80.15 Billion JPY | 6.58% |
| 2024 Q2 | 81.6 Billion JPY | 1.81% |
| 2024 Q3 | 87.55 Billion JPY | 7.29% |
| 2024 FY | 365 Billion JPY | 21.65% |
| 2023 Q3 | 73.81 Billion JPY | -7.5% |
| 2023 Q1 | 71.2 Billion JPY | 3.21% |
| 2023 FY | 300.03 Billion JPY | 18.41% |
| 2023 Q4 | 75.2 Billion JPY | 1.88% |
| 2023 Q2 | 79.8 Billion JPY | 12.07% |
| 2022 Q3 | 63.99 Billion JPY | 2.62% |
| 2022 Q4 | 68.99 Billion JPY | 7.81% |
| 2022 Q1 | 58.02 Billion JPY | -6.78% |
| 2022 Q2 | 62.36 Billion JPY | 7.47% |
| 2022 FY | 253.38 Billion JPY | 11.02% |
| 2021 Q4 | 62.24 Billion JPY | 8.52% |
| 2021 FY | 228.23 Billion JPY | -2.18% |
| 2021 Q1 | 50.79 Billion JPY | -16.64% |
| 2021 Q2 | 57.83 Billion JPY | 13.86% |
| 2021 Q3 | 57.35 Billion JPY | -0.83% |
| 2020 Q2 | 56.31 Billion JPY | 0.55% |
| 2020 FY | 233.32 Billion JPY | 6.12% |
| 2020 Q4 | 60.93 Billion JPY | 1.44% |
| 2020 Q3 | 60.07 Billion JPY | 6.68% |
| 2020 Q1 | 56 Billion JPY | -0.31% |
| 2019 Q1 | 53.98 Billion JPY | 40.4% |
| 2019 FY | 219.86 Billion JPY | 4.31% |
| 2019 Q4 | 56.17 Billion JPY | -0.89% |
| 2019 Q3 | 56.67 Billion JPY | 6.9% |
| 2019 Q2 | 53.02 Billion JPY | -1.78% |
| 2018 Q3 | 60.51 Billion JPY | 19.24% |
| 2018 Q1 | 54.9 Billion JPY | -0.26% |
| 2018 FY | 210.77 Billion JPY | 4.65% |
| 2018 Q2 | 50.75 Billion JPY | -7.55% |
| 2018 Q4 | 38.44 Billion JPY | -36.47% |
| 2017 Q4 | 55.04 Billion JPY | 10.66% |
| 2017 Q3 | 49.74 Billion JPY | 3.05% |
| 2017 Q2 | 48.26 Billion JPY | -0.21% |
| 2017 FY | 201.42 Billion JPY | -0.87% |
| 2017 Q1 | 48.37 Billion JPY | -8.16% |
| 2016 FY | 203.19 Billion JPY | 7.76% |
| 2016 Q1 | 49.59 Billion JPY | -2.29% |
| 2016 Q2 | 50.65 Billion JPY | 2.14% |
| 2016 Q3 | 50.27 Billion JPY | -0.75% |
| 2016 Q4 | 52.66 Billion JPY | 4.75% |
| 2015 FY | 188.56 Billion JPY | 6.7% |
| 2015 Q3 | 47.86 Billion JPY | 5.52% |
| 2015 Q4 | 50.76 Billion JPY | 6.06% |
| 2015 Q1 | 44.59 Billion JPY | -3.72% |
| 2015 Q2 | 45.35 Billion JPY | 1.72% |
| 2014 Q3 | 43.73 Billion JPY | 1.67% |
| 2014 Q4 | 46.31 Billion JPY | 5.9% |
| 2014 FY | 176.72 Billion JPY | 15.9% |
| 2014 Q1 | 43.66 Billion JPY | 4.92% |
| 2014 Q2 | 43.01 Billion JPY | -1.48% |
| 2013 Q1 | 36.21 Billion JPY | -3.38% |
| 2013 Q4 | 41.61 Billion JPY | 8.03% |
| 2013 Q3 | 38.51 Billion JPY | 6.62% |
| 2013 Q2 | 36.12 Billion JPY | -0.23% |
| 2013 FY | 152.47 Billion JPY | 7.69% |
| 2012 Q1 | 33.46 Billion JPY | 14.89% |
| 2012 FY | 141.59 Billion JPY | 30.87% |
| 2012 Q2 | 35.08 Billion JPY | 4.84% |
| 2012 Q4 | 37.47 Billion JPY | 5.36% |
| 2012 Q3 | 35.57 Billion JPY | 1.39% |
| 2011 Q4 | 29.12 Billion JPY | 11.29% |
| 2011 FY | 108.19 Billion JPY | 4.97% |
| 2011 Q3 | 26.17 Billion JPY | -1.25% |
| 2011 Q2 | 26.5 Billion JPY | 0.43% |
| 2011 Q1 | 26.38 Billion JPY | -2.24% |
| 2010 Q1 | 25.06 Billion JPY | -4.55% |
| 2010 FY | 103.06 Billion JPY | -1.09% |
| 2010 Q3 | 25.35 Billion JPY | -1.17% |
| 2010 Q4 | 26.99 Billion JPY | 6.46% |
| 2010 Q2 | 25.65 Billion JPY | 2.37% |
| 2009 FY | 104.2 Billion JPY | 2.9% |
| 2009 Q4 | 26.25 Billion JPY | 4.53% |
| 2009 Q3 | 25.11 Billion JPY | -6.31% |
| 2009 Q2 | 26.81 Billion JPY | 0.0% |
| 2008 FY | 101.26 Billion JPY | 6.73% |
| 2007 FY | 94.87 Billion JPY | 8.52% |
| 2006 FY | 87.42 Billion JPY | 14.04% |
| 2005 FY | 76.65 Billion JPY | 4.1% |
| 2004 FY | 73.64 Billion JPY | 9.34% |
| 2003 FY | 67.34 Billion JPY | -99.96% |
| 2002 FY | 186957.24 Billion JPY | 320977.91% |
| 2001 FY | 58.22 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -11842033.295% |
| Ansell Limited | 495.5 Million USD | -68331.685% |
| Ansell Limited | 495.5 Million USD | -68331.685% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -409396.981% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -19591280.876% |
| Psykey, Inc. | 1.21 Million USD | -27942593.74% |
| ConvaTec Group Plc | 910.31 Million USD | -37148.503% |
| ConvaTec Group Plc | 872.5 Million USD | -38762.923% |
| Encision Inc. | 3.77 Million USD | -8977975.036% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -239106175.254% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -308447016.828% |
| Innovative MedTech Inc. | 6.09 Million USD | -5559482.627% |
| LifePoint, Inc. | 7.42 Million USD | -4567315.647% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -5340567.822% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -39658262.573% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -46696377.51% |
| Reflect Scientific, Inc. | 1.06 Million USD | -31877245.001% |
| SmileDirectClub, Inc. | 517 Million USD | -65485.5% |
| Sector 10, Inc. | 39.84 Thousand USD | -851016364.21% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -5004.28% |
| SheerVision, Inc. | 2.33 Million USD | -14542442.036% |
| United Health Products, Inc. | 2.42 Million USD | -13973670.873% |
| Vasamed, Inc. | 4.67 Million USD | -7256164.506% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -13235846.232% |
| Yubo International Biotech Limited | 1.25 Million USD | -26956394.087% |